Stability of response to secukinumab over 52 weeks, M. Augustin et al

preview_player
Показать описание
Author video for 'Continued treatment with secukinumab is associated with high retention or regain of response'

  1. British Journal of Dermatology
Рекомендации по теме
Stability of response 0:02:56

Stability of response to secukinumab over 52 weeks, M. Augustin et al

Short-Term Effectiveness, Safety, 0:00:30

Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab... | RTCL.TV

Characterization of responder 0:00:36

Characterization of responder groups to secukinumab treatment in moderate to severe p... | RTCL.TV

Flexible dosing of 0:03:20

Flexible dosing of secukinumab in patients with psoriasis weighing ≥90 kg, M. Augustin et al

Dr. Atul Deodhar 0:02:12

Dr. Atul Deodhar - Treating AS with Secukinumab

Malignancy risk in 0:01:07

Malignancy risk in secukinumab-treated patients, M. Lebwohl et al

Secukinumab demonstrates improvements 0:00:53

Secukinumab demonstrates improvements in absolute and relative psoriasis area severit... | RTCL.TV

Low rates of 0:02:46

Low rates of radiographic progression with secukinumab treatment in PsA patients | Douglas Veale

Increasing Secukinumab Dose 0:01:45

Increasing Secukinumab Dose in Ankylosing Spondylitis Nonresponders

Secukinumab Effect on 0:02:57

Secukinumab Effect on CV Risks in PsA, axSpA: Dr. Sheila Reyes: Dr. Sheila Reyes

How Cosentyx (secukinumab) 0:03:12

How Cosentyx (secukinumab) Works in Plaque Psoriasis

Secukinumab 0:05:29

Secukinumab

IDEF Educational Series 0:46:47

IDEF Educational Series The Latest Approved Indication for COSENTYX secukinumab

Long-term efficacy of 0:03:39

Long-term efficacy of secukinumab in palmoplantar psoriasis, A.B. Gottlieb et al

IL-23 Inhibitors and 0:24:02

IL-23 Inhibitors and Other Emerging Psoriasis Treatments

Discussing PsA: Secukinumab 0:30:34

Discussing PsA: Secukinumab & The Effect of Sex on the Long-Term Persistence of Targeted Therapi...

Biologic drug survival 0:04:29

Biologic drug survival in psoriasis, Z.Z.N. Yiu et al.

Webinar Implication of 1:36:51

Webinar Implication of Secukinumab therapies in Psoriatic Disease conditions

Sustained efficacy in 0:05:13

Sustained efficacy in nail psoriasis with secukinumab treatment, K. Reich et al

QD192 - IBD 0:06:03

QD192 - IBD or IL-17 induced Colitis?

Laura K. Ferris, 0:01:55

Laura K. Ferris, MD, PhD - Do IL-17 inhibitors work more quickly than IL-23 inhibitors and what...

The Current State 0:50:01

The Current State of Psoriasis Treatment with Targeted Therapy

Psoriatic Arthritis: Overcoming 1:00:19

Psoriatic Arthritis: Overcoming Barriers to Improve Patient Outcomes

Analysis of serum 0:00:45

Analysis of serum proteomics data identifies a quantitative association between beta-... | RTCL.TV